on of diabetes in the NOD mouse by oral administration of porcine insulin. Proc Natl Acad Sci USA,1991, 88:10252-10256 13 Lider O, Santos LMB, Lee CSY, et al. Suppression of experimental allergic encephalomyellitis by oral administration of myelin basic protein. II. suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes. J Immunol, 1989, 142:748-752
14 Miller A, Lider O, Weiner HL. Antigen-driven bystander suppression after oral administration of antigens. J Exp Med, 1991, 174:791-798
15 Sun JB, Holmgren, Czerkinsky C. Cholera toxin B subunit:an efficient transmucosal carrierdelivery system for induction of peripheral immunological tolerance. Proc Natl Acad Sci USA, 1994, 91:10795-10799
16 Sun JB, Rask C, Olsson T, et al. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subuint. Proc Natl Acad Sci USA, 1996, 93:7196-7201
17 Ma CG, Zhang GX, Xiao BG, et al. Suppression of experimental autoimmune myasthenia gravis by nasal administration of acaetylcholine receptor. J neuroimmunol, 1995, 58:51-60
18 Ma CG, Zhang GX, Xiao BG, et al. Cellular mRNA expression of IFN-γ IL-4 and TGF-β in rat nasally tolerized against experimental autoimmune myasthenia gravis. Clin Exp Immunol, 1996, 104:509-517
19 Weiner HL, Mackin GA, Matsui M, et al. Double-blind pilot trial of tolerization with myelin antigens in multiple sclerosis. Science. 1993,259:1321-1324
20 Weiner HL, Friedman A, Miller A, et al. Oral tolerance:Immunologic mechanisms and treatment of murine and human organ-specific autoimmune diseases by oral administration of autoantigens. Ann Rev Immunol, 1994, 12:809-837
21 Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunology Today, 1997, 18:335-343
22 Trentham DE, Dynesium-Trentham A, Orav EJ, et al. Effects of oral administratiion of type II c
上一页 [1] [2] [3] [4] [5] 下一页
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文